Mariette, X., & Lorenz, H. (2017). The effect of body mass index on clinical response to abatacept as a first-line biologic for rheumatoid arthritis: 6-month results from the 2-year, observational, prospective ACTION study. Joint bone spine, 84(5), . https://doi.org/10.1016/j.jbspin.2016.10.011
Chicago-Zitierstil (17. Ausg.)Mariette, Xavier, und Hanns-Martin Lorenz. "The Effect of Body Mass Index on Clinical Response to Abatacept as a First-line Biologic for Rheumatoid Arthritis: 6-month Results from the 2-year, Observational, Prospective ACTION Study." Joint Bone Spine 84, no. 5 (2017). https://doi.org/10.1016/j.jbspin.2016.10.011.
MLA-Zitierstil (9. Ausg.)Mariette, Xavier, und Hanns-Martin Lorenz. "The Effect of Body Mass Index on Clinical Response to Abatacept as a First-line Biologic for Rheumatoid Arthritis: 6-month Results from the 2-year, Observational, Prospective ACTION Study." Joint Bone Spine, vol. 84, no. 5, 2017, https://doi.org/10.1016/j.jbspin.2016.10.011.